The present study unravels distinct therapeutic properties of taxol-treated MSC-derived exosomes with the expression of predominant anti-tumor miR patterns and increased tumor tropism via an elevated SDF-1/CXCR4/CXCR7 axis. This evidence concerns the gene CXCL12 and neoplasm.